Bill Deegan
Oprichter bij Cellebration Life Sciences, Inc.
Profiel
Bill Deegan is the founder of Cellebration Life Sciences, Inc. He was previously the Chief Financial Officer, Secretary & Treasurer at American Housing Income Trust, Inc.
Actieve functies van Bill Deegan
| Bedrijven | Functie | Begin |
|---|---|---|
Cellebration Life Sciences, Inc.
 Cellebration Life Sciences, Inc. BiotechnologyHealth Technology Cellebration Life Sciences, Inc. is a regenerative technology company that is seeking FDA approval to conduct type 2 diabetes clinical trials using stem cell-based treatment. The company is based in Phoenix, AZ and was founded by Siddharth Bhavsar, Tim Kopatich, Deven Patel, Anand Srivastava, and Bill Deegan. The company has partnered with the Institute of Stem Cell Therapy and Research to provide research and treatments for autoimmune diseases and orthopedic injuries. Cellebration's research team is working closely with scientists at Giostar to find cures. Tim Kopatich has been the CEO since incorporation. | Oprichter | - |
Eerdere bekende functies van Bill Deegan
| Bedrijven | Functie | Einde |
|---|---|---|
American Housing Income Trust, Inc.
 American Housing Income Trust, Inc. Real Estate Investment TrustsFinance American Housing Income Trust, Inc. engages in the investment, acquisition, management, renovation, rehabilitation, and leasing of single-family residential properties. The company was founded on December 17, 2007 and is headquartered in Phoenix, AZ. | Financieel Directeur/CFO | 24-06-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
American Housing Income Trust, Inc.
American Housing Income Trust, Inc. Real Estate Investment TrustsFinance American Housing Income Trust, Inc. engages in the investment, acquisition, management, renovation, rehabilitation, and leasing of single-family residential properties. The company was founded on December 17, 2007 and is headquartered in Phoenix, AZ. | Finance |
Cellebration Life Sciences, Inc.
Cellebration Life Sciences, Inc. BiotechnologyHealth Technology Cellebration Life Sciences, Inc. is a regenerative technology company that is seeking FDA approval to conduct type 2 diabetes clinical trials using stem cell-based treatment. The company is based in Phoenix, AZ and was founded by Siddharth Bhavsar, Tim Kopatich, Deven Patel, Anand Srivastava, and Bill Deegan. The company has partnered with the Institute of Stem Cell Therapy and Research to provide research and treatments for autoimmune diseases and orthopedic injuries. Cellebration's research team is working closely with scientists at Giostar to find cures. Tim Kopatich has been the CEO since incorporation. | Health Technology |
